Verisante Technology Inc. (VRSEF)
OTCMKTS
· Delayed Price · Currency is USD
0.0022
0.00 (0.00%)
Jun 22, 2025, 8:00 PM EDT
Verisante Technology Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
18
Market Cap
96.66K USD
Revenue Chart
* This company reports financials in CAD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Elite Pharmaceuticals | 70.00M |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| American Oncology Network | 1.76B |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.70M |
Verisante Technology News
- 3 months ago - Verisante Technology, Inc. Announces Termination of Proposed RTO with SunRegen Healthcare AG - Accesswire
- 6 months ago - Verisante Technology, Inc. Announces RTO Update: - Accesswire
- 8 months ago - Verisante Technology, Inc. Announces Update to Proposed RTO with SunRegen Healthcare AG - Accesswire
- 11 months ago - Verisante Technology, Inc. Announces Proposed RTO with SunRegen Healthcare AG - Accesswire
- 1 year ago - Verisante Technology, Inc. Announces Exchange Acceptance of Shares for Debt Transaction - Accesswire
- 1 year ago - Verisante Technology, Inc. Announces Shares for Debt Agreements - Accesswire
- 1 year ago - Verisante Technology, Inc. Announces 2023 AGM Results - Accesswire
- 1 year ago - Verisante Technology, Inc. Announces Exchange Approval for Shares for Debt Transaction - Accesswire